Αποτελέσματα αναζήτησης - "тромбоэмболия"

Πηγή: The Russian Archives of Internal Medicine; Том 15, № 6 (2025); 468-479 ; Архивъ внутренней медицины; Том 15, № 6 (2025); 468-479 ; 2411-6564 ; 2226-6704

Θεματικοί όροι: осложнения, pulmonary embolism, diagnostics, treatment, clinical picture, acute kidney injury, complications, тромбоэмболия лег очной артерии, диагностика, лечение, клиническая картина, острое повреждение почек

Περιγραφή αρχείου: application/pdf

Relation: https://www.medarhive.ru/jour/article/view/2135/1459; Никулина Н.Н., Тереховская Ю.В. Эпидемиология тромбоэмболии легочной артерии в современном мире: анализ заболеваемости, смертности и проблем их изучения. Российский кардиологический журнал. 2019;(6):103-108. doi:10.15829/1560-4071-2019-6-103-108; Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405; Tehrani BN, Batchelor WB, Spinosa D. High-risk acute pulmonary embolism: where do we go from here? J Am Coll Cardiol. 2024;83(1):44-46. doi:10.1016/j.jacc.2023.11.001; Alashram R, Male E, Rali P. Epidemiology of pulmonary embolism. In: Pulmonary Embolism: from acute PE to chronic complications, B. Rivera-Lebron, G.A. Heresi (eds.), Springer Nature Switzerland AG 2020;1:1-12. doi:10.1007/978-3-030-51736-6_1; Grosse SD, Nelson RE, Nyarko KA, et al. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res. 2016;137:3-10. doi:10.1016/j.thromres.2015.11.033; Turetz M, Sideris AT, Friedman OA, et al. Epidemiology, pathophysiology, and natural history of pulmonary embolism. Semin Intervent Radiol. 2018;35(2):92-98. doi:10.1055/s-0038-1642036; Smith SB, Geske JB, Kathuria P, et al. Analysis of national trends in admissions for pulmonary embolism. Chest. 2016;150(1):35-45. doi:10.1016/j.chest.2016.02.638; Willich SN, Chuang LH, van Hout B, et al. Pulmonary embolism in Europe — Burden of illness in relationship to healthcare resource utilization and return to work. Thromb Res. 2018;170:181-191. doi:10.1016/j.thromres.2018.02.009; Бокерия ЛА, Затевахин ИИ, Кириенко АИ, и др. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений (ВТЭО). Флебология. 2015; 9(4-2):1-52.; Farmakis IT, Keller K, Barco S, et al. From acute pulmonary embolism to post-pulmonary embolism sequelae. Vasa. 2023;52(1):29-37. doi:10.1024/0301-1526/a001042; Opitz CF, Meyer FJ. Pulmonary embolism: an update based on the revised AWMF-S2k Guideline. Hamostaseologie. 2024;44(2):111-118. doi:10.1055/s-0044-1779011; Мензоров МВ, Филимонова ВВ, Эрлих АД, и др. Частота и прогностическое значение острого повреждение почек при тромбоэмболии лёгочной артерии по данным регистра СИРЕНА. Российский кардиологический журнал. 2022;27(1S):4864. doi:10.15829/1560-4071-2022-4864.; See EJ, Jayasinghe K, Glassford N, et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and metaanalysis of cohort studies using consensus definitions of exposure. Kidney Int. 2019;95(1):160-172. doi:10.1016/j.kint.2018.08.036; Shapiro J, Reichard A, Muck PE. New diagnostic tools for pulmonary embolism detection. Methodist Debakey Cardiovasc J. 2024;20(3):5-12. doi:10.14797/mdcvj.1342; Ватутин НТ, Тарадин ГГ, Канишева ИВ и др. Роль интервенционных методов в лечении острой легочной эмболии. Архивъ внутренней медицины. 2018;8(5):346-360. doi:10.20514/2226-6704-2018-0-5-346-360.; Игнатенко ГА, Тарадин ГГ, Ватутин НТ и др. Современные взгляды на антикоагулянтную и тромболитическую терапию острой легочной эмболии. Архивъ внутренней медицины. 2019;9(5):348-366. doi:10.20514/2226-6704-2019-9-5-348-366.; Медведев АП, Федоров СА, Трофимов НА и др. Ошибки диагностики и лечения тромбоэмболии легочной артерии. Кардиология и сердечно-сосудистая хирургия. 2021;14(1):54-59. doi:10.17116/KARDIO20211401154.; Макарова НВ, Бусалаева ЕИ, Туйзарова ИА и др. Сложности диагностики тромбоэмболии легочной артерии в клинической практике. Ульяновский медико-биологический журнал. 2022;3:35-42. doi:10.34014/2227-1848-2022-3-35-42.; Ватутин НТ, Тарадин ГГ, Костогрыз ВБ и др. Случай неоднократных синкопальных состояний при рецидивирующей тромбоэмболии легочной артерии. Кардиология 2017;57(S3):76–80. doi:10.18087/cardio.2398.; Morrone D, Morrone V. Acute pulmonary embolism: focus on the clinical picture. Korean Circ J. 2018;48(5):365-381. doi:10.4070/kcj.2017.0314; Holder T, Sullivan AE, Truong T, et al. Identification, diagnosis, treatment, and in-hospital outcomes of acute pulmonary embolism: results from a single integrated health system. Am Heart J. 2019;216:136-142. doi:10.1016/j.ahj.2019.06.016; Yao D, Cao W, Liu X. Clinical manifestations and misdiagnosis factors of pulmonary embolism patients seeking treatment in cardiology. Medicine (Baltimore). 2024;103(49):e40821. doi:10.1097/MD.0000000000040821; Панченко ЕП, Балахонова ТВ, Данилов НМ и др. Диагностика и лечение тромбоэмболии легочной артерии: клинические рекомендации Евразийской ассоциации кардиологов для практических врачей (2021). Евразийский кардиологический журнал. 2021;(1):44-77. doi:10.38109/2225-1685-2021-1-44-77; Филимонова ВВ, Мензоров МВ, Большакова АЮ. Острое повреждение почек у пациентов с тромбоэмболией легочной артерии. Ульяновский медико-биологический журнал. 2021; 2: 36–45. doi:10.34014/2227-1848-2021-2-36-45.; Chang CH, Fu CM, Fan PC, et al. Acute kidney injury in patients with pulmonary embolism: a population-based cohort study. Medicine (Baltimore). 2017;96(9):e5822. doi:10.1097/MD.0000000000005822; Alhassan AM, Aldayel A, Alharbi A, et al. Acute kidney injury in patients with suspected pulmonary embolism: a retrospective study of the incidence, risk factors, and outcomes in a tertiary care hospital in Saudi Arabia. Cureus. 2022;14(1):e21198. doi:10.7759/cureus.21198; Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386-9. doi:10.1016/s0140-6736(98)07534-5; Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J. 2005;26(20):2166-72. doi:10.1093/eurheartj/ehi336; Wang D, Fan G, Liu X, et al. Renal insufficiency and short-term outcomes of acute pulmonary embolism: a systemic review and metaanalysis. Thromb Haemost. 2020;120(7): 1025-1034. doi:10.1055/s-0040-1712459; Мензоров МВ, Филимонова ВВ, Эрлих АД и др. Почечная дисфункция у пациентов с тромбоэмболией лёгочной артерии по данным регистра СИРЕНА. Российский кардиологический журнал. 2021;26(S2):4422. doi:10.15829/1560-4071-2021-4422; Климкин ПФ, Михайлова ЗД, Екимовских АЮ и др. Нарушение функции почек у больных острой тромбоэмболией легочной артерии: как улучшить прогноз и тактику ведения? Клиническая нефрология. 2022;14(2):42-46. doi:10.18565/nephrology.2022.2.42-46.; Thomas ME, Blaine C, Dawnay A, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87(1):62-73. doi:10.1038/ki.2014.328; Kellum JA, Romagnani P, Ashuntantang G, et al. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. doi:10.1038/s41572-021-00284-z; Yoon SY, Kim JS, Jeong KH, et al. Acute kidney injury: biomarker-guided diagnosis and management. Medicina (Kaunas). 2022;58(3):340. doi:10.3390/medicina58030340; Pływaczewska M, Pruszczyk P, Kostrubiec M. Does kidney function matter in pulmonary thromboembolism management? Cardiol J. 2022;29(5):858-865. doi:10.5603/CJ.a2021.0005; Banerjee D, Ali MA, Wang AY, et al. Acute kidney injury in acute heart failure — when to worry and when not to worry? Nephrol Dial Transplant. 2024;40(1):10-18. doi:10.1093/ndt/gfae146; Boorsma EM, Ter Maaten JM, Voors AA, et al. Renal compression in heart failure: the renal tamponade hypothesis. JACC Heart Fail. 2022;10(3):175-183. doi:10.1016/j.jchf.2021.12.005; Шутов АМ, Ефремова ЕВ, Мензоров МВ и др. Современная концепция почечный континуум (острое повреждение почек, острая болезнь почек, хроническая болезнь почек). Архивъ внутренней медицины. 2021; 11(2): 94-97. doi:10.20514/2226-6704-2021-11-2-94-97.; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. doi:10.1016/j.kint.2023.10.018; Сторожаков ГИ, Осканова РС, Ильченко ЛЮ и др. Гипоксический гепатит. Архивъ внутренней медицины. 2014;(6):42-47. doi:10.20514/2226-6704-2014-0-6-42-47; https://www.medarhive.ru/jour/article/view/2135

Διαθεσιμότητα: https://www.medarhive.ru/jour/article/view/2135
https://doi.org/10.20514/2226-6704-2025-15-6-468-479

View record from BASE

5

Academic Journal

Subclinical pulmonary thromboembolism in the context of cardiovascular pathology: a case report ; TROMBOEMBOLISM PULMONAR SUBCLINIC ÎN CONTEXTUL PATOLOGIEI CARDIOVASCULARE: CAZ CLINIC ; Субклинический легочный тромбоэмболизм в контексте сердечно-сосудистой патологии: клинический случай

Συγγραφείς: TELINSCHII, Artemie, MEDVEDEVA , Ecaterina, SIRBU, Adelina, RANGA , Doina, MATCOVSCHI, Sergiu, CORLATEANU, Olga, TALMACI , Cornelia, CAPROSH, Natalia

Πηγή: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 80 No. 3 (2024): Medical Sciences; 229-231 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 80 Nr. 3 (2024): Ştiinţe medicale; 229-231 ; Вестник Академии Наук Молдовы. Медицина; Том 80 № 3 (2024): Медицина; 229-231 ; 1857-0011

Θεματικοί όροι: тромбоэмболия легочной артерии, сердечно-сосудистая патология, trombembolism pulmonar, patologie cardiovasculară, pulmonary thromboembolism, cardiovascular pathology

Περιγραφή αρχείου: application/pdf

Relation: https://bulmed.md/bulmed/article/view/3750/3741; https://bulmed.md/bulmed/article/view/3750

Διαθεσιμότητα: https://bulmed.md/bulmed/article/view/3750
https://doi.org/10.52692/1857-0011.2024.3-80.40

View record from BASE

6

Academic Journal

Pulmonary embolism in postmenopausal women: a case report ; TROMBEMBOLISM PULMONAR LA FEMEI IN MENOPAUZĂ: PREZENTARE DE CAZ ; Тромбоэмболия лёгочной артерии у женщин в постменопаузе: клинический случай

Συγγραφείς: RANGA , Doina, SHVETS, Svetlana, CEALAN , Andrei, MATCOVSCHI, Sergiu, SIRBU , Ion, CAPROSH, Hristiana, TALMACI , Cornelia, CAPROSH , Natalia

Πηγή: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 80 No. 3 (2024): Medical Sciences; 225-228 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 80 Nr. 3 (2024): Ştiinţe medicale; 225-228 ; Вестник Академии Наук Молдовы. Медицина; Том 80 № 3 (2024): Медицина; 225-228 ; 1857-0011

Θεματικοί όροι: Тромбоэмболия легочной артерии, женщины, Trombembolismul pulmonar, femei, Pulmonary thromboembolism, women

Περιγραφή αρχείου: application/pdf

Relation: https://bulmed.md/bulmed/article/view/3749/3740; https://bulmed.md/bulmed/article/view/3749

Διαθεσιμότητα: https://bulmed.md/bulmed/article/view/3749
https://doi.org/10.52692/1857-0011.2024.3-80.39

View record from BASE

7

Academic Journal

Venous and arterial thromboses in ART programs: epidemiology and preventive strategies ; Венозные и артериальные тромбозы в программах ВРТ: эпидемиология и превентивные стратегии

Συγγραφείς: V. O. Bitsadze, J. Kh. Khizroeva, E. Grandone, R. I. Gabidullina, M. V. Tretyakova, N. A. Makatsariya, N. R. Gashimova, K. N. Grigoreva, A. V. Vorobev, A. V. Lazarchuk, M. M. Muravyova, A. G. Krendeleva, T. E. Polyakova, M. S. Zainulina, D. L. Kapanadze, F. E. Yagubova, J.-C. Gris, I. Elalamy, G. Gerotziafas, P. Van Dreden, A. D. Makatsariya, В. О. Бицадзе, Д. Х. Хизроева, Э. Грандоне, Р. И. Габидуллина, М. В. Третьякова, Н. А. Макацария, Н. Р. Гашимова, К. Н. Григорьева, А. В. Воробьев, А. В. Лазарчук, М. М. Муравьёва, А. Г. Кренделева, Т. Е. Полякова, М. С. Зайнулина, Д. Л. Капанадзе, Ф. Э. Ягубова, Ж.-К. Гри, И. Элалами, Г. Геротзиафас, П. Ван Дреден, А. Д. Макацария

Συνεισφορές: The authors declare no funding, Авторы заявляют об отсутствии финансовой поддержки

Πηγή: Obstetrics, Gynecology and Reproduction; Vol 19, No 3 (2025); 377-388 ; Акушерство, Гинекология и Репродукция; Vol 19, No 3 (2025); 377-388 ; 2500-3194 ; 2313-7347

Θεματικοί όροι: риск тромбообразования, IVF, assisted reproductive technologies, ART, ovarian stimulation, thrombosis, ovarian hyperstimulation syndrome, OHSS, thrombophilia, venous thromboembolism, arterial thrombosis, risk factors, thrombosis prevention, thrombogenesis risk, ЭКО, вспомогательные репродуктивные технологии, ВРТ, стимуляция яичников, тромбоз, синдром гиперстимуляции яичников, СГЯ, тромбофилия, венозная тромбоэмболия, артериальный тромбоз, факторы риска, профилактика тромбозов

Περιγραφή αρχείου: application/pdf

Relation: https://www.gynecology.su/jour/article/view/2494/1346; Calhaz-Jorge C., De Geyter C.H., Kupka M.S. et al. Survey on ART and IUI: legislation, regulation, funding and registries in European countries: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod Open. 2020;2020(1):hoz044. https://doi.org/10.1093/hropen/hoz044.; European IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE); Smeenk J., Wyns C., De Geyter C. et al. ART in Europe, 2019: results generated from European registries by ESHRE. Hum Reprod. 2023;3(12):2321–38. https://doi.org/10.1093/humrep/dead197.; Farquhar C., Marjoribanks J., Brown J. et al. Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance. Reprod Biomed Online. 2017;35(1):3–16. https://doi.org/10.1016/j.rbmo.2017.03.024.; Nelson S.M. Venous thrombosis during assisted reproduction: novel risk reduction strategies. Thromb Res. 2013;131 Suppl 1:S1–3. https://doi.org/10.1016/S0049-3848(13)00023-6.; Grandone E., Villani M. Assisted reproductive technologies and thrombosis. Thromb Res. 2015;135 Suppl 1:S44–5. https://doi.org/10.1016/S0049-3848(15)50441-6.; Kupka M.S., Ferraretti A.P., de Mouzon J. et al.; European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†. Hum Reprod. 2014;29(10):2099–113. https://doi.org/10.1093/humrep/deu175.; Sennström M., Rova K., Hellgren M. et al. Thromboembolism and in vitro fertilization – a systematic review. Acta Obstet Gynecol Scand. 2017;96(9):1045–52. https://doi.org/10.1111/aogs.13147.; Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90(5 Supple):S188–93. https://doi.org/10.1016/j.fertnstert.2008.08.034.; Grandone E., Colaizzo D., Vergura P. et al. Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation. Hum Reprod. 2004;19(8):1796–9. https://doi.org/10.1093/humrep/deh346.; Henriksson P., Westerlund E., Wallén H. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2013;346:е8632. https://doi.org/10.1136/bmj.e8632.; Rova K., Passmark H., Lindqvist P.G. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97(1):95–100. https://doi.org/10.1016/j.fertnstert.2011.10.038.; Nelson S.M. Prophylaxis of VTE in women – during assisted reproductive techniques. Thromb Res. 2009;123 Suppl 3:S8–S15. https://doi.org/10.1016/S0049-3848(09)70127-6.; Hansen A.T., Kesmodel U.S., Juul S., Hvas A.M. No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study. Hum Reprod. 2012;27(5):1499–503. https://doi.org/10.1093/humrep/des041.; Serour G.I., Aboulghar M., Mansour R. et al. Complications of medically assisted conception in 3,500 cycles. Fertil Steril. 1998;70(4):638–42. https://doi.org/10.1016/s0015-0282(98)00250-7.; Girolami A., Scandellari R., Tezza F. et al. Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature. J Thromb Thrombolysis. 2007;24(2):169–74. https://doi.org/10.1007/s11239-007-0009-9.; Chan W.S. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009;21(3):207–18. https://doi.org/10.1097/GCO.0b013e328329c2b8.; Yang S., Yuan J., Qin W. et al. The clinical characteristics of acute cerebrovascular accidents resulting from ovarian hyperstimulation syndrome. Eur Neurol. 2017;77(5–6):221–30. https://doi.org/10.1159/000463383.; Filipovic-Pierucci A., Gabet A., Deneux-Tharaux C. et al. Arterial and venous complications after fertility treatment: a French nationwide cohort study. Eur J Obstet Gynecol Reprod Biol. 2019;237:57–63. https://doi.org/10.1016/j.ejogrb.2019.02.034.; Chan W.S, Dixon M.E. The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008;121(6):713–26. https://doi.org/10.1016/j.thromres.2007.05.023.; Villani M., Favuzzi G., Totaro P. et al. Venous thromboembolism in assisted reproductive technologies: comparison between unsuccessful versus successful cycles in an Italian cohort. J Thromb Thrombolysis. 2018;45(2):234–9. https://doi.org/10.1007/s11239-017-1584-z.; Mozes M., Bogokowsky H., Antebi E. et al. Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet. 1965;2(7424):1213–5. https://doi.org/10.1016/s0140-6736(65)90636-7.; Kermode A.G., Churchyard A., Carroll W.M. Stroke complicating severe ovarian hyperstimulation syndrome. Aust N Z J Med. 1993;23(2):219–20. https://doi.org/10.1111/j.1445-5994.1993.tb01823.x.; Inbar O.J., Levran D., Mashiach S., Dor J. Ischemic stroke due to induction of ovulation with clomiphene citrate and menotropins without evidence of ovarian hyperstimulation syndrome. Fertil Steril. 1994;62(5):1075–6. https://doi.org/10.1016/s0015-0282(16)57078-2.; Cluroe A.D., Synek B.J. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology. 1995;27(4):344–6. https://doi.org/10.1080/00313029500169273.; Chan W.S., Ginsberg J.S. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost. 2006;4(8):673–7. https://doi.org/10.1111/j.1538-7836.2006.02026.x.; Fleming T., Sacks G., Nasser J. Internal jugular vein thrombosis following ovarian hyperstimulation syndrome. Aust N Z J Obstet Gynaecol. 2012;52(1):87–90. https://doi.org/10.1111/j.1479-828X.2011.01392.x.; Salomon O., Schiby G., Heiman Z. et al. Combined jugular and subclavian vein thrombosis following assisted reproductive technology – new observation. Fertil Steril. 2009;92(2):620–5. https://doi.org/10.1016/j.fertnstert.2008.07.1708.; Aboulghar M.A., Mansour R.T., Serour G.I., Amin Y.M. Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis. Hum Reprod. 1998;13(8):2088–91. https://doi.org/10.1093/humrep/13.8.2088.; Kodama H., Fukuda J., Karube H. et al. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil Steril. 1995;64(6):1207–9. https://doi.org/10.1016/s0015-0282(16)57987-4.; Delvigne A., Demoulin A., Smitz J. et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod. 1993;8(9):1353–60. https://doi.org/10.1093/oxfordjournals.humrep.a138260.; Dulitzky M., Cohen S.B., Inbal A. et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertil Steril. 2002;77(3):463–7. https://doi.org/10.1016/s0015-0282(01)03218-6.; Grandone E., Di Micco P.P., Villani M. et al.; RIETE Investigators. Venous thromboembolism in women undergoing assisted reproductive technologies: Data from the RIETE Registry. Thromb Haemost. 2018;118(11):1962–8. https://doi.org/10.1055/s-0038-1673402.; Olausson N., Discacciati A., Nyman A.I. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: nationwide cohort study. J Thromb Haemost. 2020;18(8):1965–73. https://doi.org/10.1111/jth.14840.; Abramov Y., Elchalal U., Schenker J.G. Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril. 1998;70(6):1070–6. https://doi.org/10.1016/s0015-0282(98)00350-1.; Bauersachs R.M., Manolopoulos K., Hoppe I. et al. More on: the 'ART' behind the clot: solving the mystery. J Thromb Haemost. 2007;5(2):438–9.; Richardson M.A., Berg D.T., Calnek D.S. et al. 17beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathway. Endocrinology. 2000;141(10):3908–11. https://doi.org/10.1210/endo.141.10.7798.; Rogolino A., Coccia M.E., Fedi S. et al. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul Fibrinolysis. 2003;14(3):277–82. https://doi.org/10.1097/01.mbc.0000061296.28953.d0.; Ricci G., Bogatti P., Fischer-Tamaro L. et al. Factor V Leiden and prothrombin gene G20210A mutation and in vitro fertilization: prospective cohort study. Hum Reprod. 2011;26(11):3068–77. https://doi.org/10.1093/humrep/der261.; Goualou M., Noumegni S., de Moreuil C. et al. Venous thromboembolism associated with assisted reproductive technology: a systematic review and meta-analysis. Thromb Haemost. 2023;123(3):283–94. https://doi.org/10.1055/s-0042-1760255.; Pabinger I., Grafenhofer H., Kaider A. et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005;3(5):949–54. https://doi.org/10.1111/j.1538-7836.2005.01307.x.; Milenkovic J., Milojkovic M., Mitic D. et al. Interaction of thrombophilic SNPs in patients with unexplained infertility-multifactor dimensionality reduction (MDR) model analysis. J Assist Reprod Genet. 2020;37(6):1449–58. https://doi.org/10.1007/s10815-020-01808-4.; Santos T.D.S., Ieque A.L., de Carvalho H.C. et al. Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis. J Reprod Immunol. 2017;123:78–87. https://doi.org/10.1016/j.jri.2017.09.007.; El Hasbani G., Khamashta M., Uthman I. Antiphospholipid syndrome and infertility. Lupus. 2020;29(2):105–17. https://doi.org/10.1177/0961203319893763.; Qublan H.S., Eid S.S., Ababneh H.A. et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod. 2006;21(10):2694–8. https://doi.org/10.1093/humrep/del203.; Nesbit C., Gunalp C., Zhang J. et al. Longitudinal assessment of coagulation potential before, during, and following an in vitro fertilization cycle. Thromb Res. 2024;238:97–102. https://doi.org/10.1016/j.thromres.2024.04.020.; Azem F., Many A., Ben Ami I. et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19(2):368–70. https://doi.org/10.1093/humrep/deh069.; Hansen A.T., Kesmodel U.S., Juul S., Hvas A.M. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod. 2014;29(3):611–7. https://doi.org/10.1093/humrep/det458.; Refsum H., Nurk E., Smith A.D. et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006;136(6 Suppl):1731S–1740S. https://doi.org/10.1093/jn/136.6.1731S.; Fuchs H.E., O'Connell K., Du M. et al. Vitamin B12 supplementation and vitamin B12 blood serum levels: evaluation of effect modification by gender and smoking status. Nutr Cancer. 2022;74(7):2373–83. https://doi.org/10.1080/01635581.2021.2007271.; Bazzano L.A., He J., Muntner P. et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138(11):891–7. https://doi.org/10.7326/0003-4819-138-11-200306030-00010.; Villani M., Dentali F., Colaizzo D. et al. Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort. BMJ Open. 2015;5(10):e008213. https://doi.org/10.1136/bmjopen-2015-008213.; Rosendaal F.R. Risk factors for venous thrombotic disease. Thromb Haemost. 1999;82(2):610–9.; Grandone E., Ageno W. The legacy of Edwards and Steptoe and the windy roads of assisted reproduction: where do we stand with venous thromboembolism? Thromb Haemost. 2023;123(3):267–9. https://doi.org/10.1055/a-1996-1341.; Yinon Y., Pauzner R., Dulitzky M. et al. Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events. Reprod Biomed Online. 2006;12(3):354–8. https://doi.org/10.1016/s1472-6483(10)61009-7.; Bates S.M., Greer I.A., Middeldorp S. et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S–e736S. https://doi.org/10.1378/chest.11-2300.; Grandone E., Piazza G. Thrombophilia, inflammation, and recurrent pregnancy loss: a case-based review. Semin Reprod Med. 2021;39(1–02):62–8. https://doi.org/10.1055/s-0041-1731827.; Sticchi E., Romagnuolo I., Cellai A.P. et al. Fibrinolysis alterations in infertile women during controlled ovarian stimulation: influence of BMI and genetic components. Thromb Res. 2012;130(6):919–24. https://doi.org/10.1016/j.thromres.2012.07.005.; Gurunath S., Vinekar S., Biliangady R. Assisted reproductive techniques in a patient with history of venous thromboembolism: a case report and review of literature. J Hum Reprod Sci. 2018;11(2):193–7. https://doi.org/10.4103/jhrs.JHRS5817.; Westerlund E., Antovic A., Hovatta O. et al. Changes in von Willebrand factor and ADAMTS13 during IVF. Blood Coagul Fibrinolysis. 2011;22(2):127–31. https://doi.org/10.1097/MBC.0b013e32834363ea.; https://www.gynecology.su/jour/article/view/2494

Διαθεσιμότητα: https://www.gynecology.su/jour/article/view/2494
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.656

View record from BASE

8

Academic Journal

Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer ; Система гемостаза и метастазирование: терапевтический потенциал антикоагулянтов при раке яичников

Συνεισφορές: The authors declare no funding, Авторы заявляют об отсутствии финансовой поддержки

Πηγή: Obstetrics, Gynecology and Reproduction; Vol 19, No 3 (2025); 351-359 ; Акушерство, Гинекология и Репродукция; Vol 19, No 3 (2025); 351-359 ; 2500-3194 ; 2313-7347

Περιγραφή αρχείου: application/pdf

Relation: https://www.gynecology.su/jour/article/view/2493/1343; Sung H., Ferlay J., Siegel R.L. at al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660; Бредихин Р.А., Ахметзянов Р.В., Хайруллин Р.Н. Расширение возможностей лечения и профилактики венозных тромбоэмболических осложнений у пациентов с онкологическими заболеваниями. Роль пероральных антикоагулянтов. Клиницист. 2022;16(2):17–26. https://doi.org/10.17650/1818-8338-2022-16-2-К667.; Mulder F.I., Horváth-Puhó E., van Es N. et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959–69. https://doi.org/10.1182/blood.2020007338.; Streiff M.B. Thrombosis in the setting of cancer. Hematology Am Soc Hematol Educ Program. 2016;2016(1):196–205. https://doi.org/10.1182/asheducation-2016.1.196.; Guo J., Gao Y., Gong Z. et al. Plasma D-dimer level correlates with age, metastasis, recurrence, tumor-node-metastasis classification (TNM), and treatment of non-small-cell lung cancer (NSCLC) patients. Biomed Res Int. 2021;2021:9623571. https://doi.org/10.1155/2021/9623571.; Hisada Y., Mackman N. Tissue factor and cancer: regulation, tumor growth and metastasis. Semin Thromb Hemost. 2019;45(4):385–95. https://doi.org/10.1055/s-0039-1687894.; Zhao B., Wu M., Hu Z. et al. A novel oncotherapy strategy: direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non-small cell lung cancer. Br J Pharmacol. 2022;179(22):5056–73. https://doi.org/10.1111/bph.15384.; Hisada Y., Mackman N. Cancer-associated pathways and biomarkers of venous thrombosis. Blood. 2017;130(13):1499–506. https://doi.org/10.1182/blood-2017-03-743211.; Слуханчук Е.В., Бицадзе В.О., Хизроева Д.Х. и др. Тромбоциты, тромбовоспаление и онкологический процесс. Акушерство, Гинекология и Репродукция. 2021;15(6):755–76. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.274.; Stone R.L., Nick A.M., McNeish I.A. et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610–8. https://doi.org/10.1056/NEJMoa1110352.; Zhou L., Zhang Z., Tian Y. et al. The critical role of platelet in cancer progression and metastasis. Eur J Med Res. 2023;28(1):385. https://doi.org/10.1186/s40001-023-01342-w.; Miyazaki M., Nakabo A., Nagano Y. et al. Tissue factor-induced fibrinogenesis mediates cancer cell clustering and multiclonal peritoneal metastasis. Cancer Lett. 2023;553:215983. https://doi.org/10.1016/j.canlet.2022.215983.; Cohen A.T., Hamilton M., Mitchell S.A. et al. Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thrombo-embolism: systematic review and network meta-analysis. PLoS One. 2015;10(12):e0144856. https://doi.org/10.1371/journal.pone.0144856.; Farge D., Frere C., Connors J.M. et al.; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022;23(7):e334–e347. https://doi.org/10.1016/S1470-2045(22)00160-7.; Key N.S., Khorana A.A., Kuderer N.M. et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Guideline Update. J Clin Oncol. 2023;41(16):3063–71. https://doi.org/10.1200/JCO.23.00294.; Kurube I., Ambari E., Iskandar T. et al. Factors associated with recurrence of epithelial ovarian cancer In RSUP Dr. Kariadi Semarang. DIMJ. 2022;3(2):74–80. https://doi.org/10.14710/dimj.v3i2.15448.; Joy J., Kumar J., Kumar S., Arshad M. Clinical profiles and survival outcomes of patients with relapsed ovarian cancer: a single-center study. Cureus. 2024;16(11):e74724. https://doi.org/10.7759/cureus.74724.; Al-Azzawi H.M.A., Hamza S.A., Paolini R. et al. Towards an emerging role for anticoagulants in cancer therapy: a systematic review and meta-analysis. Front Oral Health. 2024;5:1495942. https://doi.org/10.3389/froh.2024.1495942.; Najidh S., Versteeg H.H., Buijs J.T. A systematic review on the effects of direct oral anticoagulants on cancer growth and metastasis in animal models. Thromb Res. 2020;187:18–27. https://doi.org/10.1016/j.thromres.2019.12.022.; https://www.gynecology.su/jour/article/view/2493

Διαθεσιμότητα: https://www.gynecology.su/jour/article/view/2493
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.644

View record from BASE

9

Academic Journal

Recurrent thrombosis in malignant neoplasms: clinical significance of long-term anticoagulant prophylaxis ; Рецидивирующие тромбозы при злокачественных новообразованиях: клиническая значимость длительной антикоагулянтной профилактики

Πηγή: Obstetrics, Gynecology and Reproduction; Vol 19, No 2 (2025); 168-179 ; Акушерство, Гинекология и Репродукция; Vol 19, No 2 (2025); 168-179 ; 2500-3194 ; 2313-7347

Θεματικοί όροι: прямые оральные антикоагулянты, VTE, recurrent thrombosis, ovarian cancer, ОС, anticoagulant therapy, АСТ, long-term prophylaxis, deep vein thrombosis, pulmonary embolism, Khorana scale, Vienna-CATS scale, Tic-Onco scale, genetic thrombophilia, D-dimer, direct oral anticoagulants, ВТЭ, рецидивирующий тромбоз, рак яичников, РЯ, антикоагулянтная терапия, АКТ, длительная профилактика, тромбоз глубоких вен, тромбоэмболия легочной артерии, шкала Khorana, шкала Vienna-CATS, шкала Tic-Onco, генетическая тромбофилия, D-димер

Περιγραφή αρχείου: application/pdf

Relation: https://www.gynecology.su/jour/article/view/2426/1318; Becattini C., Di Nisio M., Franco L. et al. Treatment of venous thromboembolism in cancer patients: the dark side of the moon. Cancer Treat Rev. 2021;96:102190. https://doi.org/10.1016/j.ctrv.2021.102190.; Cohen A., Lim C.S., Davies A.H. Venous thromboembolism in gynecological malignancy. Int J Gynecol Cancer. 2017;27(9):1970–8. https://doi.org/10.1097/IGC.0000000000001111.; Salinaro J.R., McQuillen K., Stemple M. et al. Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2020;30(4):491–7. https://doi.org/10.1136/ijgc-2019-000980.; Moufarrij S., Sassine D., Basaran D., Jewell E.L. Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: a literature review. Gynecol Oncol. 2023;170:167–71. https://doi.org/10.1016/j.ygyno.2023.01.012.; Marques I.S., Tavares V., Savva-Bordalo J. et al. Long non-coding RNAs: bridging cancer-associated thrombosis and clinical outcome of ovarian cancer patients. Int J Mol Sci. 2023;25(1):140. https://doi.org/10.3390/ijms25010140.; Дерябина В.А., Матухин В.И., Рухляда Н.Н. и др. Риски тромботических осложнений у пациентов с раком яичников и некоторые аспекты безопасности применения антифибринолитических гемостатических средств. Акушерство и гинекология. 2023;(10):60–9. https://doi.org/10.18565/aig.2023.107.; Han L., Chen Y., Zheng A., Chen H. Incidence and risk factors for venous thromboembolism in patients with ovarian cancer during neoadjuvant chemotherapy: a meta-analysis. Am J Cancer Res. 2023;13(5):2126–34.; Григорьева К.Н., Гашимова Н.Р., Цибизова В.И. Коррекция гемостаза в лечении и реабилитации пациентов с COVID-19. Реабилитология. 2023;1(1):49–59. https://doi.org/10.17749/2949-5873/rehabil.2023.3.; Levi M. Disseminated intravascular coagulation in cancer: an update. Semin Thromb Hemost. 2019;45(4):342–7. https://doi.org/10.1055/s-0039-1687890.; Khorana A.A., Kuderer N.M., Culakova E. et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–7. https://doi.org/10.1182/blood-2007-10-116327.; Khorana A.A., Mackman N., Falanga A. et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022;8(1):11. https://doi.org/10.1038/s41572-022-00336-y.; Ay C., Dunkler D., Marosi C. et al. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116(24): 377–82. https://doi.org/10.1182/blood-2010-02-270116.; Martin A.J.M., Ortega I., Font C. et al. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. Br J Cancer. 2018;118(8):1056–61. https://doi.org/10.1038/s41416-018-0027-8.; Шульман C., Макацария А.Д., Воробьев А.В. и др. Злокачественные новообразования и тромбозы. Акушерство и гинекология. 2019;(7):14–23. https://doi.org/10.18565/aig.2019.7.14-23.; Петриков А.С., Вавилова Т.В., Варданян А.В. и др. Первичная профилактика венозных тромбоэмболических осложнений низкомолекулярными гепаринами у хирургических пациентов – 2024: резолюция Совета экспертов. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2024;17(2):251–78. https://doi.org/10.17749/2070-4909/farmakoekonomika.2024.250.; Fujisaki T., Sueta D., Yamamoto E. et al. Comparing anticoagulation strategies for venous thromboembolism associated with active cancer: a systematic review and meta-analysis. JACC CardioOncol. 2024;6(1):99–113. https://doi.org/10.1016/j.jaccao.2023.10.009.; Talmor-Barkan Y., Yacovzada N.-S., Rossman H. et al. Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial. Eur Heart J Cardiovasc Pharmacother. 2022;9(1):26–37. https://doi.org/10.1093/ehjcvp/pvac063.; Cohen A.T., Hamilton M., Mitchell S.A. et al. Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: systematic review and network meta-analysis. PLoS One. 2015;10(12):e0144856. https://doi.org/10.1371/journal.pone.0144856.; Farge D., Frere C., Connors J.M. et al.; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022;23(7):e334–e347. https://doi.org/10.1016/S1470-2045(22)00160-7.; Key N.S., Khorana A.A., Kuderer N.M. et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Guideline update. J Clin Oncol. 2023;41(16):3063–71. https://doi.org/10.1200/JCO.23.00294.; Barca-Hernando M., Lopez-Ruz S., Marin-Romero S. et al. Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism. Front Cardiovasc Med. 2023;10:1118385. https://doi.org/10.3389/fcvm.2023.1118385.; Lanting V.R., Takada T., Bosch F.T.M. et al. Risk of recurrent venous thromboembolism in patients with cancer: an individual patient data meta-analysis and development of a prediction model. Thromb Haemost. 2024 Oct 16. https://doi.org/10.1055/a-2418-3960.; Khorana A.A., McCrae K.R., Milentijevic D. et al. Duration of anticoagulant therapy and VTE recurrence in patients with cancer. Support Care Cancer. 2019;27(10):3833–40. https://doi.org/10.1007/s00520-019-4661-3.; Dave H.M., Khorana A.A. Management of venous thromboembolism in patients with active cancer. Cleve Clin J Med. 2024;91(2):109–17. https://doi.org/10.3949/ccjm.91a.23017.; Moik F., Colling M., Mah? I. et al. Extended anticoagulation treatment for cancer-associated thrombosis-Rates of recurrence and bleeding beyond 6 months: a systematic review. J Thromb Haemost. 2022;20(3):619–34. https://doi.org/10.1111/jth.15599.; Хизроева Д.Х., Асланова З.Д., Солопова А.Г. и др. Роль внеклеточных ловушек нейтрофилов в прогрессии рака и развитии тромбозов. Акушерство, Гинекология и Репродукция. 2024;18(1):55–67. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.475.; Воробьев А.В., Эйнуллаева С.Э., Бородулин А.С. и др. Влияние COVID-19 на тромботические осложнения у онкологических больных. Акушерство, Гинекология и Репродукция. 2024;18(3):286–99. Https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.519.; Воробьев А.В., Солопова А.Г., Бицадзе В.О. и др. Сравнение эффективности шкал Khorana, Vienna CATS, TiC-Onco и соотношения vWF/ADAMTS13 в выявлении высокого риска тромботических осложнений у больных злокачественными новообразованиями. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2025;18(1): 71–9. https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.308.; Bertoletti L., Girard P., Elias A. et al., INNOVTE CAT Working Group. Recurrent venous thromboembolism in anticoagulated cancer patients: diagnosis and treatment. Arch Cardiovasc Dis. 2024;117(1):84–93. https://doi.org/10.1016/j.acvd.2023.11.006.; Федоткина Ю.А., Панченко Е.П. Современные подходы к профилактике венозных тромбоэмболических осложнений у пациентов с активным раком. Атеротромбоз. 2022;12(2):44–62. https://doi.org/10.21518/2307-1109-2022-12-2-44-62.; Patell R., Hsu C., Shi M. et al. Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer. Haematologica. 2024;109(6):1849–56. https://doi.org/10.3324/haematol.2023.284192.; https://www.gynecology.su/jour/article/view/2426

Διαθεσιμότητα: https://www.gynecology.su/jour/article/view/2426
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.629

View record from BASE

10

Academic Journal

VENOUS THROMBOEMBOLIC COMPLICATIONS IN TRAUMA PATIENTS ; ВЕНОЗНЫЕ ТРОМБОЭМБОЛИЧЕСКИЕ ОСЛОЖНЕНИЯ У ПАЦИЕНТОВ С ТРАВМАМИ

Συγγραφείς: Агаларян, А.Х., Агаджанян, В.В., Штофин, С.Г., Гончаров, Р.С.

Πηγή: POLYTRAUMA; № 1 (2025): март; 51-58 ; ПОЛИТРАВМА / POLYTRAUMA; № 1 (2025): март; 51-58 ; 2541-867X ; 1819-1495

Θεματικοί όροι: venous thromboembolic complications, deep vein thrombosis, pulmonary embolism, traumatic injuries, венозные тромбоэмболические осложнения, тромбоз глубоких вен, тромбоэмболия легочной артерии, травматические повреждения

Περιγραφή αρχείου: application/pdf

Relation: http://poly-trauma.ru/index.php/pt/article/view/584/833

Διαθεσιμότητα: http://poly-trauma.ru/index.php/pt/article/view/584

View record from BASE

11

Academic Journal

Chemotherapy and hemostasis disorders ; Химиотерапия и нарушения гемостаза

Συγγραφείς: E. V. Slukhanchuk, V. O. Bitsadze, A. G. Solopova, J. Kh. Khizroeva, K. N. Grigoreva, N. R. Gashimova, N. A. Makatsariya, D. V. Blinov, V. N. Galkin, A. Yu. Shatilina, E. M. Lyadnova, N. A. Shulga, L. T. Toguzaeva, S. Morkos, J.-C. Gris, I. Elalamy, G. Gerotziafas, A. D. Makatsariya, Е. В. Слуханчук, В. О. Бицадзе, А. Г. Солопова, Д. Х. Хизроева, К. Н. Григорьева, Н. Р. Гашимова, Н. А. Макацария, Д. В. Блинов, В. Н. Галкин, А. Ю. Шатилина, Е. М. Ляднова, Н. А. Шульга, Л. Т. Тогузаева, С. Моркос, Ж.-К. Гри, И. Элалами, Г. Геротзиафас, А. Д. Макацария

Πηγή: Obstetrics, Gynecology and Reproduction; Vol 18, No 6 (2024); 835-846 ; Акушерство, Гинекология и Репродукция; Vol 18, No 6 (2024); 835-846 ; 2500-3194 ; 2313-7347

Θεματικοί όροι: ХТ, venous thromboembolism, thrombosis, chemotherapy, СТ, венозная тромбоэмболия, тромбоз, химиотерапия

Περιγραφή αρχείου: application/pdf

Relation: https://www.gynecology.su/jour/article/view/2288/1279; Elyamany G., Alzahrani A.M., Bukhary E. Cancer-associated thrombosis: an overview. Clin Med Insights Oncol. 2014;8:129-37. https://doi.org/10.4137/cmo.s18991.; Heit J.A., Silverstein M.D., Mohr D.N. et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809-15. https://doi.org/10.1001archinte.160.6.809.; Blom J.W., Vanderschoot J., Oostindier M. et al. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006;4(3):529-35. https://doi.org/10.1111/j.1538-7836.2006.01804.x.; Khorana A.A., Francis C.W., Culakova E., Lyman G.H. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer. 2005;104(12):2822-9. https://doi.org/10.1002/cncr.21496.; Duggan C., Marriott K., Edwards R., Cuzick J. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer. J Clin Oncol. 2003;21(19):3588-93. https://doi.org/10.1200/JCO.2003.10.111.; Fisher B., Dignam J., Emir B. al. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst. 1997;89(22):1673-82. https://doi.org/10.1093/jnci/89.22.1673.; Clahsen P.C., Van de Velde C., Julien J.-P. et al. Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J Clin Oncol. 1994;12(6):1266-71. https://doi.org/10.1200/JCO.1994.12.6.1266.; Goodnough L.T., Saito H., Manni A. et al. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. Cancer. 1984;54(7):1264-8. https://doi.org/10.1002/1097-0142(19841001)54:73.0.co;2-r.; Cantwell B., Carmichael J., Ghani S.E., Harris A.L. Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy. BMJ. 1988;297(6642):179-80. https://doi.org/10.1136/bmj.297.6642.179.; Rickles F.R., Levine M.N. Epidemiology of thrombosis in cancer. Acta Haematol. 2001;106(1-2):6-12. https://doi.org/10.1159/000046583.; Lubiniecki G.M., Berlin J.A., Weinstein R.B., Vaughn D.J. Thromboembolic events with estramustine phosphate-based chemotherapy in patients with hormone-refractory prostate carcinoma: results of a meta-analysis. Cancer. 2004;101(12):2755-9. https://doi.org/10.1002/cncr.20673.; Kuenen B.C., Rosen L., Smit E.F. et al. Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors. J Clin Oncol. 2002;20(6):1657-67. https://doi.org/10.1200/JCO.2002.20.6.1657.; Palumbo A., Bertola A., Musto P. et al. Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma. Cancer. 2005;104(7):1428-33. https://doi.org/10.1002/cncr.21342.; Wang M., Dimopoulos M.A., Chen C. et al. Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure. Blood. 2008;112(12):4445-51. https://doi.org/10.1182/blood-2008-02-141614.; Rajkumar S.V., Blood E., Vesole D. et al. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol. 2006;24(3):431-6. https://doi.org/10.1200/JCO.2005.03.0221.; Glasmacher A., Hahn C., Hoffmann F. M, et al. A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma. Br J Haematol. 2006;132(5):584-93. https://doi.org/10.1111/j.1365-2141.2005.05914.x.; Lee C.-K., Barlogie B., Munshi N. et al. DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma. J Clin Oncol. 2003;21(14):2732-9. https://doi.org/10.1200/JCO.2003.01.055.; Steurer M., Sudmeier I., Stauder R., Gastl G. Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha. Br J Haematol. 2003;121(1):101-3. https://doi.org/10.1046/j.1365-2141.2003.04252.x.; Palladini G., Russo P., Milani P. et al. A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis. Haematologica. 2013;98(3):433-6. https://doi.org/10.3324/haematol.2012.073593.; van Es N., Sturk A., Middeldorp S., Nieuwland R. Effects of cancer on platelets. Semin Oncol. 2014;41(3):311-8. https://doi.org/10.1053/j.seminoncol.2014.04.015.; Thaler J., Pabinger I., Sperr W.R., Ay C. Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia. Thromb Res. 2014;133(3):303-5. https://doi.org/10.1016/j.thromres.2013.12.029.; Swystun L.L., Mukherjee S., Liaw P.C. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost. 2011;9(11):2313-21. https://doi.org/10.1111/j.1538-7836.2011.04465.x.; Kirwan C.C., Mccollum C.N., McDowell G., Byrne G. Investigation of proposed mechanisms of chemotherapy-induced venous thromboembolism: endothelial cell activation and procoagulant release due to apoptosis. Clin Appl Thromb Hemost. 2015;21(5):420-7. https://doi.org/10.1177/1076029615575071.; Chen L., Deng H., Cui H. et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204-18. https://doi.org/10.18632/oncotarget.23208.; Mo J., Zhang D., Yang R. Expression of P-selectin, VCAM-1, and PSGL-1 in traumatic deep venous thrombosis. Int J Clin Exp Pathol. 2016;9(3):3403-9.; Feng Y., Li X., Xiao J. et al. ADAMTS13: more than a regulator of thrombosis. Int J Hematol. 2016;104(5):534-9. https://doi.org/10.1007/s12185-016-2091-2.; Бицадзе В.О., Слуханчук Е.В., Хизроева Д.Х. и др. Внеклеточные ловушки нейтрофилов (NETs) в патогенезе тромбоза и тромбовоспа-лительных заболеваний. Вестник Российской академии медицинских наук. 2021;76(1):75-85. https://doi.org/10.15690/vramn1395.; Izzedine H., Isnard-Bagnis C., Launay-Vacher V. Gemcitabine-induced thrombotic microangiopathy: a systematic review. Nephrol Dial Transplant. 2006;21(11):3038-45. https://doi.org/10.1093/ndt/gfl507.; Ohtsu H., Dempsey P.J., Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol. 2006;291(1):C1-C10. https://doi.org/10.1152/ajpcell.00620.2005.; Choi M.K., Hong J.Y., Jang J.H., Lim H.Y. TTP-HUS associated with sunitinib. Cancer Res Treat. 2008;40(4):211-3. https://doi.org/10.4143/crt.2008.40.4.211.; Ojeda-Uribe M., Merieau S., Guillon M. et al. Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate. J Oncol Pharm Pract. 2016;22(2):361-70. https://doi.org/10.1177/1078155214568580.; Biss T., Avery P., Williams M. et al. The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in children. J Thromb Haemost. 2013;11(2):373-5. https://doi.org/10.1111/jth.12072.; Terrell D., Williams L., Vesely S. et al. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005;3(7):1432-6. https://doi.org/10.1111/j.1538-7836.2005.01436.x.; Okano E., Ko S., Kanehiro H. et al. ADAMTS13 activity decreases after hepatectomy, reflecting a postoperative liver dysfunction. Hepatogastroenterology. 2010;57(98):316-20.; Liu L., Choi H., Bernardo A. et al. Platelet-derived VWF-cleaving metalloprotease ADAMTS-13. J Thromb Haemost. 2005;3(11):2536-44. https://doi.org/10.1111/j.1538-7836.2005.01561.x.; Sato N., Tasaki T., Noguchi H. et al.The pathological challenge of establishing a precise diagnosis for pulmonary tumour thrombotic microangiopathy: identification of new diagnostic criteria. Histopathology. 2019;74(6):892-901. https://doi.org/10.1111/his.13813.; Turner N.A., Nolasco L., Ruggeri Z.M., Moake J.L. Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. Blood. 2009;114(24):5102-11. https://doi.org/10.1182/blood-2009-07-231597.; Van Es N., Le Gal G., Otten H.-M. et al. Screening for occult cancer in patients with unprovoked venous thromboembolism: a systematic review and meta-analysis of individual patient data. Ann Intern Med. 2017;167(6):410-7. https://doi.org/10.7326/M17-0868.; Lee M., Rodansky E.S., Smith J.K., Rodgers G.M. ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis. Microvas Res. 2012;84(2):109-15. https://doi.org/10.1016/j.mvr.2012.05.004.; Feys H., Liu F., Dong N. et al. ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences. J Thromb Haemost. 2006;4(5):955-62. https://doi.org/10.1111/j.1538-7836.2006.01833.x.; Kearon C., Akl E.A., Ornelas J. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315-52. https://doi.org/10.1016/j.chest.2015.11.026.; Hedrick C.C., Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted. Nat Rev Immunol. 2022;22(3):173-87. https://doi.org/10.1038/s41577-021-00571-6.; Kan M., Imaoka H., Watanabe K. et al. Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study. Cancer Chemother Pharmacol. 2020;86(2):203-10. https://doi.org/10.1007/s00280-020-04110-3.; Kasi P.M., Grothey A. Chemotherapy-induced neutropenia as a prognostic and predictive marker of outcomes in solid-tumor patients. Drugs. 2018;78:737-45. https://doi.org/10.1007/s40265-018-0909-3.; Zhang Y., Guoqiang L., Sun M., Lu X. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment. Cancer Biol Med. 2020;17(1):32—43. https://doi.org/10.20892/j.issn.2095-3941.2019.0372.; Schwarzenbach H., Hoon D.S., Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426—37. https://doi.org/10.1038/nrc3066.; Lee Y.J., Yoon K.-A., Han J.-Y. et al. Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy circulating DNA in prognosis of advanced NSCLC. Clin Cancer Res. 2011;17(15):5179—87. https://doi.org/10.1158/1078-0432.CCR-11-0400.; Слуханчук Е.В., Бицадзе В.О., Солопова А.Г. и др. Маркеры внеклеточных ловушек нейтрофилов у женщин со злокачественными новообразованиями репродуктивной системы, получавших хирургическое лечение и адъювантную терапию. Акушерство, Гинекология и Репродукция. 2023;17(4):420-32. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.432.; Demers M., Wagner D.D. Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology. 2013;2(2):e22946. https://doi.org/10.4161/onci.22946.; Holdenrieder S., Stieber P., von Pawel J. et al. Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer. Clin Cancer Res. 2004;10(18 Pt 1):5981—7. https://doi.org/10.1158/1078-0432.CCR-04-0625.; Fuchs T.A., Kremer Hovinga J.A., Schatzberg D. et al. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood. 2012;120(6):1157-64. https://doi.org/10.1182/blood-2012-02-412197.; Elmoamly S., Mattar M., Yacoub M.F., Afif A. Can biomarkers of coagulation, platelet activation, and inflammation predict venous thromboembolism in patients with haematological malignancies? Acta Haematol. 2019;141(4):245-53. https://doi.org/10.1159/000496914.; Marconi S., Croce M., Chiorino G. et al. A circulating risk score, based on combined expression of exo-miR-130a-3p and fibrinopeptide a, as predictive biomarker of relapse in resectable non-small cell lung cancer patients. Cancers. 2022;14(14):3412. https://doi.org/10.3390/cancers14143412.; Edwards R.L., Klaus M., Matthews E. et al. Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels. Am J Med. 1990;89(1):25-8. https://doi.org/10.1016/0002-9343(90)90093-s.; Zurborn K.H., Gram J., Glander K. et al. Influence of cytostatic treatment on the coagulation system and fibrinolysis in patients with non-Hodgkin's lymphomas and acute leukemias. Eur J Haematol. 1991;47(1):55-9.; Stahli B.E., Camici G.G., Steffel J. et al. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res. 2006;99(2):149-55. https://doi.org/10.1161/01.RES.0000233379.92010.fd.; Adamson I.Y., Bowden D.H. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol. 1974;77(2):185-97.; Bertomeu M., Gallo S., Lauri D. et al. Chemotherapy enhances endothelial cell reactivity to platelets. Clin Exp Metastasis. 1990;8(6):511-8. https://doi.org/10.1007/BF00135874.; Sobierajska K., Ciszewski W.M., Sacewicz-Hofman I., Niewiarowska J. Endothelial cells in the tumor microenvironment. Adv Exp Med Biol. 2020;1234:71-86. https://doi.org/10.1007/978-3-030-37184-5_6.; Li C.-X., He Q., Wang Z.-Y. et al. Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model. Head Neck. 2023;45(10):2515-24. https://doi.org/10.1002/hed.27475.; van der Schoot G.G.F., Ormel H.L., Westerink N.-D.L. et al. Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis. J Cancer Res Clin Oncol. 2023;149(19):17467-78. https://doi.org/10.1007/s00432-023-05469-5.; Hamza M.S., Mousa S.A. Cancer-associated thrombosis: risk factors, molecular mechanisms, future management. Clin Appl Thromb Hemost. 2020;26:1076029620954282. https://doi.org/10.1177/1076029620954282.; Aklilu A.M., Shirali A.C. Chemotherapy-associated thrombotic microangiopathy. Kidney360. 2023;4(3):409-22. https://doi.org/10.34067/KID.0000000000000061.; Prandoni P., Campello E., editors. Venous thromboembolism in cancer patients undergoing chemotherapy: risk factors and prevention. Semin Thromb Hemost. 2021;47(8):914-9. https://doi.org/10.1055/s-0040-1718927.; Yang V., Gouveia M.J., Santos J. et al. Breast cancer: insights in disease and influence of drug methotrexate. RSC Med Chem. 2020;11(6):646-64. https://doi.org/10.1039/d0md00051e.; Sulimai N.H., Brown J., Lominadze D. Fibrinogen, fibrinogen-like 1 and fibrinogen-like 2 proteins, and their effects. Biomedicines. 2022;10(7):1712. https://doi.org/10.3390/biomedicines10071712.; Fulcher J., Carrier M. Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia-time to reconsider current approaches? Thromb Res. 2020;188:100-2. https://doi.org/10.1016/j.thromres.2020.02.015.; https://www.gynecology.su/jour/article/view/2288